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ABSTRACT
Candida infections are the most prevalent cause of serious human mycoses and are the third most 
common pathogens isolated from bloodstream infections in hospitalized patients. C. parapsilosis 
is a member of the non-albicans spp., which have a predilection for causing life-threatening 
disease in neonates and hospitalized pediatric patients. In this study, we utilized a Drosophila 
melanogaster infection model to analyze the immunological responses to C. parapsilosis. Our 
results demonstrate that the Toll pathway in Drosophila controls C. parapsilosis proliferation as 
the Toll signaling mutant MyD88−/− flies are highly susceptible to C. parapsilosis. We also con-
firmed that the MyD88−/− fly is a convenient invertebrate animal model to analyze virulence 
properties of different species and strains from the C. parapsilosis sensu lato complex as 
C. orthopsilosis, C. metapsilosis proved to be less virulent than C. parapsilosis sensu stricto and 
the N-mannan deficient C. parapsilosis och1Δ/Δ strain showed attenuated pathogenicity in this 
immunodeficient Drosophila background. We also found that Persephone protease is not required 
for detection and activation of Toll pathway during C. parapsilosis infection. Furthermore, we 
observed that Drosophila β-glucan receptor deficient flies where more sensitive to C. parapsilosis 
compared to wild-type flies; however, we could not find a clear dependence on the recognition of 
this receptor and the cell wall β-glucan exposure-induced host response. These studies establish 
this D. melanogaster infection model as an efficient tool in deciphering immune responses to 
C. parapsilosis as well as for assessing virulence factors produced by this emerging fungal 
predator.
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Introduction
Candida species are opportunistic fungal pathogens 
causing severe diseases in immunocompromised 
patients and are the third most common microorgan-
isms responsible for healthcare-related bloodstream 
infections [1]. Although C. albicans is the most fre-
quently isolated species globally as the causative agent 
for disseminated Candida diseases, the frequency of 
infections due to non-albicans Candida species con-
tinues to increase [2,3]. C. parapsilosis is ranked as 
the second or third most common non-albicans spp 
[4]. This pathogen has a particular predilection for 
causing hospital-acquired infections in neonatal and 
pediatric patients as well as adult patients with intra-
vascular catheters and other implantable devices [5,6]. 
Through investigations of C. parapsilosis biology, 
numerous factors have been identified that play roles 
in pathogenesis including extracellular lipases, tran-
scription regulators, pseudohyphae and biofilm 
production, antifungal resistance mechanisms, and 
iron metabolic processes [6–8].
Since virulence-related genes in various Candida 
spp. require validated models to define their function, 
experimental in vivo models are essential in pathogen-
esis research. The fruit fly, Drosophila melanogaster is 
a remarkably flexible invertebrate model organism to 
study specific responses of innate immunity against 
microbial infections [9,10]. This mini-host has been 
applied to examine innate immune defense mechan-
isms against certain Candida species, as flies deficient 
in the Toll signaling pathway are sensitive to fungal 
infections [11]. The Toll/Dif pathway responds to the 
presence of fungal and Gram-positive bacterial infec-
tions and mediates the production of antimicrobial 
peptides (AMPs), such as Drosomycin, Metchnikowin, 
and Defensins [12–14]. After it is activated by 
a proteolytic cleavage cascade, Spätzle (spz) is a ligand 
for Toll and binds to the cell transmembrane receptor, 
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triggering its dimerization, which leads to the recruit-
ment of the adaptor, Drosophila myeloid differentia-
tion factor 88 (dMyD88, homolog of mammalian 
MyD88). Upstream of Spätzle, immune detection of 
fungal determinants is regulated by the Gram-negative 
binding protein 3 (GNBP3) and the Persephone (psh) 
serine protease [15]. The GNBP3, a member of the 
GNBP/β-glucan recognition proteins (βGRP) family, 
has been reported to bind to fungal cell wall β-(1,3)- 
glucan and activates the antifungal Toll pathway in 
a Spätzle-dependent manner [15]. Indeed, GNBP3 con-
tributes to controlling Candida infections, as 
C. albicans and C. glabrata challenged GNBP3 deficient 
flies display increased susceptibility/death events and 
impaired expression levels of the Toll-dependent 
Drosomycin gene [15,16]. Psh encodes 
a hemolymphatic serine protease belonging to 
a Drosophila danger pathway and becomes activated 
by proteolytic activities of microbes that induce Toll 
signaling [15]. The lack of psh causes a weak suscept-
ibility of adult flies to C. albicans, but psh mutant flies 
are highly susceptible to C. glabrata challenge [16,17]. 
The contribution of these sensor molecules in Candida 
defense can vary depending on the Drosophila model 
selected. For example, gastrointestinal infection with 
C. albicans in Drosophila larvae generated a GNBP3 
independent, but psh-Toll dependent systemic 
response, which required the presence of hemo-
cytes [18].
A broad range of research has demonstrated that 
Drosophila models are reliable tools for screening new 
antifungal treatment options against C. albicans [11] 
and C. auris [19] and investigating genes involved in 
Candida pathogenesis. Different virulence factors, such 
as C. albicans Cas5, a transcriptional regulator of genes 
involved in cell wall integrity [20] and secreted aspartyl 
proteases SAP4 and SAP6 [18], as well as C. glabrata 
Yapsins (secreted GPI-anchored aspartyl proteases) 
[16] and ADA2 for oxidative stress tolerance were 
identified in this mini-host [21].
In this study, we aimed to describe C. parapsilosis 
infection in an immunodeficient D. melanogaster fly 
model, which we adapted from the work previously 
performed to characterize C. albicans and C. glabrata 
induced specific immune responses [16]. We demon-
strated that C. parapsilosis infection is highly regulated 
by the Drosophila Toll pathway, as MyD88 mutant flies 
succumbed to challenge with C. parapsilosis cells. We 
extended our studies to include additional members of 
the C. parapsilosis sensu lato complex, and demon-
strated that this type of immunodeficient fly is suitable 
to analyze the differences in virulence of the 
C. parapsilosis sensu lato complex strains. We also 
found, as reported in mouse models, that 
a C. parapsilosis without a proper N-mannan layer in 
the cell wall was significantly less virulent in our fly 
model. Our results show that D. melanogaster and 
mutants like MyD88−/- Drosophila are extremely useful 




Drosophila stocks were maintained on standard corn-
meal agar medium at 25°C, in 12 h light/12 h dark cycle 
according to Drosophila Protocols, Chapter 35 
(Sullivan, Ashburner, Hawley, Cold Spring Harbor 
Laboratory Press, 2000). The wild-type w1118 (BL3605) 
(from Bloomington Stock Center) and Drosomycin- 
GFP (GFP-Drs-fly) [22], GNBP3hades, psh, and MyD88 
mutant flies (a kind gift from Jessica Quintin) were 
used in this study. Stocks have been described pre-
viously [23].
Microbial strains
C. parapsilosis GA1 (SZMC 8110) [24], C. parapsilosis 
CLIB 214 (SZMC 1560) [25] C. parapsilosis SZMC 
1592, C. parapsilosis SZMC 8050, C. albicans SC5314 
(SZMC 1523), C. metapsilosis SZMC 1548, 
C. metapsilosis SZMC 8099, C. metapsilosis SZMC 
8094, C. orthopsilosis SZMC 1545, C. orthopsilosis 
SZMC 8121 and C. orthopsilosis SZMC 8119 [26] wild- 
type strains, C. parapsilosis och1Δ/Δ, C. parapsilosis 
CPRI [27], a GFP-expressing derivative of 
C. parapsilosis CLIB 214 (genotype: CpNEUT5L/ 
CpNEUT5L::pECpOE-GFP-N-N5L) and C. albicans 
SC5314 (RPS1/RPS1::CIp10-PTDH3-GFP-CaNAT1) 
were used in this study and maintained on YPD agar 
plates (0.5% yeast extract, 1% peptone, 1% glucose, 
2.5% agar) at 4°C. The C. parapsilosis CPRI strain was 
used as a reference for the analysis of infections with 
C. parapsilosis och1∆/∆ strain. Prior to use, Candida 
cells were grown in liquid YPD medium (0.5% yeast 
extract, 1% peptone, and 1% glucose supplemented 
with 1% Penicillin-Streptomycin) with shaking 
(200 rpm) at 30°C overnight. Micrococcus luteus 
SZMC 0264 (Szeged, Hungary), a Gram-positive bac-
teria, was used as a reference for the Drosomycin induc-
tion studies. M. luteus was grown in an overnight 
culture in LB broth (1% tryptone, 0.5% yeast extract 
and 0.5% NaCl) at 37°C with 200 rpm shaking. Prior to 
use, microbial cells were harvested by centrifugation, 
washed twice with PBS (phosphate-buffered saline; 
137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 
2 mM KH2PO4; pH 7.4), counted using 
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a hemocytometer and adjusted to the proper concen-
tration detailed for each experiment.
Survival study of flies
Batches of 15 (2- to 4-day-old females and males; 
45 per experimental group) wild-type (wt) and mutant 
flies were infected by septic injury on the dorsal side of 
the thorax. The flies were injected using a 30 g needle 
previously dipped into PBS or a 2×107/ml suspension 
of bacteria or yeasts. The vials containing the chal-
lenged flies were housed in an incubator (29°C for 
fungal infections or 25°C for bacterial challenges). 
Survival was assessed daily, and live flies were put 
into new vials containing standard cornmeal agar med-
ium every second day. Results are expressed as 
a percentage of surviving flies at different days post- 
infection.
Even though it may not be ideal for examining the 
virulence of human pathogens at temperatures below 
37°C, the incubation of flies at 29°C is a good compro-
mise to avoid the physiological consequences of the 
heat-shock response. We choose this methodology 
according to our experiences and previous work of 
Davis et al., where they demonstrated that performance 
of Drosophila-fungus interaction at 29°C is suitable for 
examining C. albicans virulence factors and this tem-
perature has no adverse effect on the yeast dissemina-
tion and the development of pseudohyphae and 
hyphae [28].
Fungal burden assay
Groups of 10 infected flies were homogenized in PBS at 
specific times (right after the infection (input), 5 hours 
(0 day), 2 days, and 4 days) after the PBS and Candida 
(2×107/ml) infection. The homogenates were serially 
diluted, plated on YPD agar plates, and incubated for 
48 h at 30°C to enable colony growth for counting. 
Yeast colonies recovered from flies were calculated 
and expressed as CFU/fly. Results are pooled data 
from five independent experiments.
In vivo phagocytosis assay
Flies were infected with 20 μl of a 1×105/ml GFP- 
labeled Candida strain suspension using a sharpened 
glass capillary on the thorax and then the insects were 
incubated for 3 h at 25°C. Collection of hemocytes was 
performed according to a standard method [29]. 
Briefly, flies were anaesthetized and the last section of 
the abdomen was removed. The fly’s thorax was punc-
tured with a sharpened glass capillary. Perfusion was 
performed through a capillary with a Schneider’s med-
ium (Biowest, cat.: L0207) containing 1-phenyl- 
2-thiourea (PTU, Sigma-Aldrich, cat.: P7629). The 
samples collected from five flies per group were placed 
on glass slides and incubated for 30 min to allow 
hemocytes to adhere to the slides. After the incubation, 
the medium was removed, and non-phagocytosed 
yeasts were labeled with 5 μM of Calcofluor white 
(5 mM, Sigma-Aldrich, cat.: 18,909–100ML-F) at 
room temperature for 10 min and then washed two 
times with PBS to remove excess stain. Samples were 
fixed for 5 min in 4% formaldehyde in PBS, permeabi-
lized for 5 min in 0.1% Triton X-100 and filamentous 
actin of Drosophila hemocytes was stained with Texas 
Red®-X Phalloidin (Thermofisher, cat.: T7471) (1:250) 
for 20 min. After washing steps with PBS, samples were 
covered with SlowFade mounting medium (Invitrogen, 
cat.: S36917) and the slides analyzed with a BX51 
OLYMPUS microscope.
RNA isolation and qPCR
The measurement of Drosomycin mRNA level was 
designed and performed according to a standard 
method [30]. Samples of five flies/group were frozen 
in liquid nitrogen and total RNA was isolated using the 
Quick-RNA MiniPrep Kit (Zymo Research, cat.: R1054) 
according to the manufacturer’s instructions. The con-
centration and integrity of isolated RNA were con-
firmed by ND-1000 Spectrophotometer (Thermo 
Scientific). cDNA was synthesized from 2000 ng total 
RNA using the RevertAidTM First Strand cDNA 
Synthesis Kit (Thermo Scientific, cat.: K1622) accord-
ing to the manufacturer’s protocol. qRT-PCR was per-
formed using Maxima SYBR Green qPCR Master Mix 
(Thermo Scientific, cat.: K0242), in a C1000TM Thermal 
Cycler (BIO-RAD) equipped with a CFX96™ Real-Time 
Detector System (BIO-RAD). Ribosomal protein 49 
(Rp49) was used as an endogenous control gene, and 
fold changes were calculated by the ΔΔCt method. PCR 
product specificity was confirmed by melting analysis. 
Primer sequences were as follows: rp49: forward: 5’ 
GACGCTTCAAGGGACAGTATCTG 3’, reverse: 5’ 
AAACGCGGTTCTGCATGAG 3’; drosomycin: forward 
5’ CGTGAGAACCTTTTCCAATATGATG 3’, reverse: 
5’ TCCCAGGACCACCAGCAT 3’ [30].
Detection of Drosomycin production by microscopy
GFP-Drs-flies were injected with 2×108/ml Candida or 
bacterial suspension [22]. After 24 h of incubation, flies 
were anaesthetized for direct observation of 
Drosomycin induction. Microscopy was performed 
using an OLYMPUS SZX7 stereomicroscope.
Statistical analysis
Graphs represent at least three independent experi-
ments (n ≥ 3 in each experiment) that yielded similar 
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results unless otherwise stated (see Results and Figure 
legends for details). Results from the fungal burden and 
real-time PCR analysis are expressed as mean ± SEM. 
Diagrams were created and statistical analyses were 
performed with the GraphPad Prism 7.0 software. 
Differences were considered statistically significant at 
p ≤ 0.05.
Results
Toll pathway involvement in Candida infection
To determine if D. melanogaster are susceptible to 
C. parapsilosis and whether the Toll signaling pathway 
regulates disease, we injected wild-type (wt fly) and 
MyD88−/- flies with C. parapsilosis GA1 or C. albicans 
SC5314 strain, as reference. As expected, there was no 
significant difference in survival rates of wt flies 
infected with the fungal species compared to the PBS 
injected flies (Figure 1(a)). Notably, MyD88−/- flies dis-
played similar susceptibility to C. albicans and 
C. parapsilosis GA1. However, with a more in-depth 
examination of the mini-host’s survival, we observed 
that more MyD88−/- flies challenged with C. parapsilosis 
survived compared to C. albicans infected flies 
(Figure 1(b)). The lower virulence of C. parapsilosis in 
the Drosophila model was previously reported by 
Chamilos et al., where the Tl mutant flies died more 
from C. albicans or C. krusei than C. parapsilosis [11]. 
Therefore, our data further strengthened the observa-
tion that the Toll pathway is required for defense 
against these opportunistic yeasts and the Drosophila 
model is suitable to distinguish between the different 
virulence potentials of distinct fungal species.
To detail the upstream events participating in the 
Toll pathway activation against C. parapsilosis, we also 
tested flies carrying a mutation in the GNBP3 receptor 
or the Persephone serine protease. During the monitor-
ing of GNBP3 deficient flies’ survival, we noted that the 
absence of GNBP3 PRR markedly affected the fly’s 
fitness and viability, as the PBS injection alone caused 
death events in our experimental settings. As expected 
from the previous studies, GNBP3hades flies nevertheless 
showed increased susceptibility to C. albicans compared 
to the PBS injected fly groups. Our data also documents 
that this receptor takes part in detecting C. parapsilosis 
cells, as the GNBP3hades flies displayed increased mor-
tality in response to this pathogen compared to the PBS 
injected fly group (Figure 1(c)). Furthermore, we 
observed that psh−/- flies were resistant to 
C. parapsilosis and C. albicans (Figure 1(d)).
Effect of Candida infection on antimicrobial peptide 
gene expression
Upon fungal challenge, the Drosophila pathogen recog-
nition receptors trigger signaling pathways leading to 
the production of the antifungal peptide Drosomycin. 
Figure 1. Comparison of the survival of wt (a), MyD88−/- (b), GNBP3hades (c) and psh−/- (d) flies after injection with PBS, C. albicans 
SC5314 or C. parapsilosis GA1. Infection dose 2 × 107 yeast/ml. n = 45 fly/group/experiment. Results are representative of 4 
independent experiments with statistical analysis by Mantel–COX test. P value style: GP: **** p < 0,0001; not significant (ns)<0.1234.
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Drosomycin mRNA-level measurement has been used 
as a readout of Toll pathway activation, and its induc-
tion was reported upon Candida infections [15]. 
Therefore, we challenged a transgenic Drosophila line 
expressing the GFP-Drosomycin fusion protein [22] to 
examine the response induced by C. parapsilosis. We 
used M. luteus as bacterial [31] and C. albicans as 
fungal reference. As survival of wt, MyD88−/- and 
GNBP3hades flies showed no significant difference 
between infection with C. parapsilosis GA1, 
C. parapsilosis CLIB 214 and C. parapsilosis CPRI 
strains (Figure S1(a-c)), we presented data performed 
with C. parapsilosis CPRI strain.
As expected, M. luteus injected flies exhibited 
a robust GFP-expression compared to the Candida 
infected fly groups (Figure 2(a)). In comparison to the 
PBS injected fly, C. albicans and C. parapsilosis chal-
lenged flies presented a strong GFP-Drosomycin 
expression, suggesting that systemic infection with 
either of the two Candida species similarly induces 
the production of this AMP in the fruit fly 
(Figure 2(a)).
To depict the activation of the humoral response 
against C. parapsilosis, we measured the mRNA level 
of Drosomycin using quantitative real-time PCR 
method in the wt, MyD88−/- and psh−/- flies. In the 
GNBP3hades fly, PBS injection alone caused higher 
Drosomycin mRNA expression in this background 
than the wt fly groups (Figure S1(d)); therefore, we 
did not include this fly strain in our analyses. After 
24 h of the infection, wt flies showed the highest 
expression of AMP after challenge with M. luteus, 
whereas the yeast species induced lower mRNA levels. 
Furthermore, C. parapsilosis provoked a significantly 
weaker humoral response compared to C. albicans 
(Figure 2(b)). In comparison to the wt fly, a mutation 
in the MyD88 adapter resulted in a significantly 
decreased level of Drosomycin after either the bacterial 
or fungal stimuli. Similarly, as reported for C. albicans 
[15,16], antifungal peptide gene induction by 
C. parapsilosis was not affected by lack of Persephone 
protease, as no differences were detected in its mRNA 
levels between the corresponding psh−/- and wt fly 
groups (Figure 2(b)).
These data confirmed the results presented by the 
survival experiments and indicate that C. parapsilosis 
infection cause Toll-mediated humoral defense in 
Drosophila.
Detection of phagocytosis upon Candida infection
We next examined in vivo phagocytosis, which is one of 
the cellular responses of the Drosophila immune sys-
tem. For this, we infected adult flies by septic injury 
Figure 2. A. GFP-Drosomycin expression of flies after 24 h of injection with M. luteus, C. albicans or C. parapsilosis CPRI. Injection dose 
1x108/ml. B. Drosomycin mRNA induction in wt, MyD88−/- and psh−/- flies after 24 h of injection with M. luteus, C. albicans (C. alb) or 
C. parapsilosis CPRI. Injection dose 5x107/ml. Data are represented as means with ± SEM from 3 independent experiments as 
determined by paired t-test. P value style: GP: **** p < 0,0001; *** p < 0,0002; not significant (ns)<0.1234. C. In vivo phagocytosis of 
GFP-C. albicans and GFP-C. parapsilosis. Flies (wt) were injected with 20 µl of 2×105/ml of GFP-C. albicans or GFP-C. parapsilosis 
strains. Hemolymph was collected (5 fly/group) 3 h after the injection, non-phagocytosed yeast were labeled with Calcofluor White, 
and hemocytes were stained with Phalloidin-Texas Red. White arrows indicate engulfed Candida cells.
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with a suspension of C. albicans or C. parapsilosis, and 
examined the phagocytosis capacity of hemocytes 
against the yeast cells. After 3 hours of incubation, we 
found that Drosophila blood cells effectively detected 
and engulfed both C. albicans and C. parapsilosis cells. 
Representative pictures show phagocytosed yeast cells 
of C. albicans and partially enveloped cells of 
C. parapsilosis (Figure 2(c)). These results confirmed 
a systemic response after C. parapsilosis septic wound-
ing and suggest a similar elimination mechanism 
against this yeast as to that described with C. albicans 
in Drosophila [32].
Assessment of virulence properties of different 
C. parapsilosis strains
As our results showed that MyD88−/- flies are suscep-
tible to C. parapsilosis challenge, we wanted to examine 
whether this fly group could be utilized to determine 
virulence differences in closely related C. parapsilosis 
sensu lato complex species. Therefore, we injected the 
wt and the MyD88−/- flies with three isolates each of 
C. parapsilosis, C. orthopsilosis or C. metapsilosis spe-
cies, and found that the MyD88−/- flies display 
increased susceptibility to the members of the 
C. parapsilosis sensu lato group compared to the PBS 
injected fly group (data not shown). As next step, we 
selected one isolate of C. parapsilosis (Cp GA1), 
C. orthopsilosis (Co 1548) and C. metapsilosis (Cm 
1546) and compared their virulence in the immune- 
deficient mini-host. In agreement with previous studies 
with another invertebrate model, Galleria mellonella 
larvae [26], our results presented that the 
C. metapsilosis infected MyD88−/- flies had significantly 
better survival rates than flies challenged with the other 
C. parapsilosis sensu lato species. Furthermore, no sig-
nificant differences were detected in the death events 
caused by the C. parapsilosis sensu stricto and 
C. orthopsilosis challenged MyD88 deficient flies 
(Figure 3).
Effect of C. parapsilosis cell wall integrity on 
pathogenesis in the D. melanogaster model
Next, to characterize the pathogenesis of C. parapsilosis 
in D. melanogaster and test whether this invertebrate 
model is suitable to assess differences in the virulence 
of mutant C. parapsilosis strains, we employed the 
C. parapsilosis CPRI reference and the mutant och1Δ/ 
Δ (Cpoch1∆/∆) for fly injection. The C. parapsilosis 
och1∆/∆ strain exhibits a severe defect in N-mannan 
content with elevated β-glucan and chitin levels in the 
cell wall. In previous studies, Cpoch1∆/∆ strain-induced 
alterations in the cytokine production in human mono-
nuclear cells and displayed significantly decreased viru-
lence in Balb/C mouse and neonate mouse model 
[27,33].
In agreement with the findings of systemic murine 
infection, our results revealed that the percentage of 
surviving MyD88−/- flies were significantly higher after 
challenged with the Cpoch1∆/∆ cells compared the 
C. parapsilosis CPRI infected fly groups (Figure 4). In 
comparison to PBS, the GNBP3hades flies died signifi-
cantly faster after challenge with the cell wall mutant 
Candida strain, but mortality rate was similar to that 
caused by C. parapsilosis CPRI. As expected, the psh 
mutant flies were resistant to Cpoch1∆/∆ infection 
(Figure 4).
For a detailed assessment of the two C. parapsilosis 
strain’s virulence properties, we analyzed the prolifera-
tion capacity of the fungi in flies using CFU determina-
tions. As shown, the wt flies were resistant to 
C. parapsilosis infection, and the CFU results show 
that these insects can rapidly kill C. parapsilosis CPRI 
cells. However, C. parapsilosis CPRI that survived the 
initial immune response were able to proliferate in 
Figure 3. Survival of wt, MyD88−/- flies after injection with PBS, C. parapsilosis GA1, C. metapsilosis, or C. orthopsilosis. Infection dose 
2 × 107 yeast/ml. n = 45 fly/group/experiment. Results are representative of 4 independent experiments with statistical analysis by 
Mantel–COX test. P value style: GP: **** p < 0,0001; * p < 0,0332; not significant (ns)<0.1234.
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these flies, as increased numbers of yeast cells were 
observed during the infection period (Figure 5) The 
susceptibility of the MyD88−/- and GNBP3hades flies to 
C. parapsilosis infection was also strengthened by the 
significantly higher fungal loads at 2 and 4 days of 
infection compared to that observed in wt flies. The 
assessment of the colonization also supported the 
resistance of psh mutant fly. The psh−/- flies showed 
that the yeast cells could survive within the mini-host, 
but the fungal loads were relatively low (Figure 5).
Notably, we detected a decrease in fungal colonies of 
Cpoch1∆/∆ infected wt and psh−/- flies from day 2 
to day 4, suggesting an enhanced clearance of the 
mutant C. parapsilosis strain by the mini-host 
Figure 4. Survival of wt, MyD88−/-, GNBP3hades and psh−/- flies after injection with C. parapsilosis CPRI or Cpoch1∆/∆. Injection dose 
2×107/ml. Results are representative of 4 independent experiments with statistical analysis by Mantel-Cox-test. P value style: GP: **** 
p < 0,0001; *** p < 0,0002; ** p < 0,0021; * p < 0,0332; not significant (ns)<0.1234.
Figure 5. CFU assessment of wt, MyD88−/-, GNBP3hades and psh−/- flies after injection with C. parapsilosis CPRI. Injection dose 2×107/ 
ml. Data are presented as mean with ± SEM from 5 independent experiments as determined by paired t-test. P value style: GP: **** 
p < 0,0001; *** p < 0,0002; ** p < 0,0021; * p < 0,0332; not significant (ns)<0.1234.
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(Figure 6). In line with the survival data, as the 
Cpoch1∆/∆ challenged MyD88−/- and GNBP3hades flies 
showed an increment in the death events compared to 
the PBS injected fly groups, these genotypes of flies 
were unable to clear the Cpoch1∆/∆ cells. However, all 
groups of flies, either sensitive to the reference 
C. parapsilosis strain or not, were able to control the 
growth of the N-mannan mutant strain, as significantly 
lower CFUs of Cpoch1∆/∆ were obtained from each fly 
background at each time point of the experiments 
compared to C. parapsilosis CPRI (Figure 6). 
Therefore, these CFU data also support the decreased 
virulence of Cpoch1∆/∆ in the immune-deficient 
Drosophila model.
Next, we tested whether the decreased virulence of 
the Cpoch1∆/∆ is commensurate with its induction of 
antifungal peptides. In comparison to the 
C. parapsilosis CPRI, Cpoch1∆/∆ induced a non- 
significant increase in Drosomycin mRNA level in 
the wt fly (Figure 7). When the MyD88−/- flies were 
infected with the Cpoch1∆/∆, we found significantly 
decreased mRNA level of the antifungal peptides fol-
lowing challenge with CPRI or Cpoch1∆/∆ compared 
to levels in wt flies, but there were again no signifi-
cant differences between the C. parapsilosis strains. 
Drosomycin expression measured from psh−/- flies 
infected with either C. parapsilosis strain were similar 
to levels in wt insects (Figure 7). Therefore, these data 
Figure 6. CFU assessment of wt, MyD88−/-, GNBP3hades and psh−/- flies after injection with C. parapsilosis CPRI and Cpoch1∆/∆. 
Injection dose 2×107/ml. Data are represented as mean with ± SEM from 5 independent experiments, Paired t-test. P value style: GP: 
**** p < 0,0001; *** p < 0,0002; ** p < 0,0021; * p < 0,0332.
Figure 7. Drosomycin mRNA induction in wt, MyD88−/- and psh−/- flies after injection with C. parapsilosis CPRI or Cpoch1∆/∆. Injection 
dose 5x107/ml. Data are presented as means with ± SEM from 3 independent experiments as determined by paired t-test. P value 
style: *** p < 0,0002; ** p < 0,0021; not significant (ns)<0.1234.
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further strengthened the results that the Toll pathway 
detects C. parapsilosis cells and the Persephone serine 
protease is not involved in its activation process.
Discussion
Here, we aimed to use D. melanogaster as a model to 
investigate the pathogenicity of C. parapsilosis. Our 
results indicate that the Drosophila Toll restrains 
C. parapsilosis proliferation as MyD88−/− flies display 
a significantly enhanced susceptibility to C. parapsilosis. 
Our data also support an earlier study where 
C. parapsilosis showed lower virulence in 
D. melanogaster compared to C. albicans [11]. We 
have further explored the capacity of this mini-host to 
sense C. parapsilosis using flies lacking the GNBP3 β- 
glucan receptor or the Persephone protease required for 
Toll pathway activation during fungal invasion. We 
found that GNBP3hades flies displayed increased sus-
ceptibility to C. parapsilosis, whereas psh mutants 
were resistant, which is similar to findings with 
C. albicans challenge in these fly strains [15]. 
Furthermore, we demonstrated that the MyD88−/- 
Drosophila strain could distinguish variations in viru-
lence between the closely related Candida species, and 
that the characterizations were similar to that found in 
our prior work using a G. mellonella model where 
C. metapsilosis was the least virulent species of the 
psilosis group and no significant divergence was 
observed between the mortality rate of larvae infected 
with C. parapsilosis sensu stricto and C. orthopsilosis 
isolates [26].
Our study examined whether immune-deficient flies 
might be useful to identify and test the variation of 
C. parapsilosis strains’ pathogenesis. The 
α1,6-mannosyltransferase Och1 initiates N-glycan 
outer chain branch addition in the yeast cell wall and 
possibly regulates virulence in both C. albicans and 
C. parapsilosis [27,34]. In the MyD88 mutant 
D. melanogaster, the lack of N-mannan content in 
C. parapsilosis altered the survival rates of infected 
flies compared to insects infected with the reference 
yeasts. The decreased virulence of C. parapsilosis lack-
ing N-mannan in this mini-host is similar to results 
found in studies using a systemic mouse infection 
model [27,33]. Albeit, the decreased virulence with 
this C. parapsilosis mutant was not paired with differ-
ences in antimicrobial peptide induction in the fly. 
A similar result was found in a gastrointestinal 
Drosophila larvae model where the C. albicans cell 
wall mutant PMR1, which has defects in both N- and 
O-linked mannosylation, activated Drosomycin to the 
same extent as did the wild-type C. albicans counter-
part strain [18].
C. parapsilosis induced Drosomycin at a significantly 
lower rate than C. albicans in wt and the psh−/- flies, 
and the flies were more resistant to C. parapsilosis. 
Also, the Cpoch1Δ/Δ strain demonstrated attenuated 
virulence in the Drosophila model, but it induced an 
antimicrobial response that was similar to the reference 
C. parapsilosis strain. There are controversial results 
regarding the fungicidal activity of Drosomycin against 
yeasts. In vitro studies noted that Drosomycin has no 
fungicidal effect on C. albicans and C. glabrata 
[16,35,36]. A study using a knockout approach of dif-
ferent AMPs deficient flies deduced that AMPs have 
may not individually be essential in defense against 
fungi and disclosed the additive cooperation of 
Drosomycin and Metchnikowin to restrain C. albicans 
infection [37].
Thus, our results indicate that it is not primarily the 
antimicrobial peptide production that performs the 
elimination function in Drosophila in controlling 
C. parapsilosis infection as it was correspondingly con-
cluded for C. albicans and C. glabrata [38].
GNBP3 is essential for controlling C. albicans and 
C. glabrata infections, as deprivation of this receptor 
caused increased susceptibility of adult flies against 
these Candida species [16,32]. Unexpectedly, in our 
experiment settings, the GNBP3hades flies were extre-
mely sensitive to injection as the survival proportion 
of the PBS treated flies was around 56%. However, the 
death events of the C. albicans or C. parapsilosis chal-
lenged fly group were significantly higher compared to 
the PBS injection. We were surprised that och1Δ/Δ and 
the reference C. parapsilosis strain infection provoked 
similar survival curves in the GNBP3 deficient flies, 
albeit the wild-type produced significantly hihger 
CFUs compared to the mutant. Therefore, we could 
not find clear interdependence between the lack of the 
N-mannosyl residues and the higher β-glucan exposure 
in the cell wall of C. parapsilosis and ligand binding of 
this Drosophila receptor.
We also found elevated Drosomycin mRNA levels in 
GNBP3hades flies compared to the wild-type Drosophila 
after the PBS injection alone. This could suggest that 
the death events of the Candida-challenged GNBP3 
receptor mutant flies were not necessarily the sole 
effect of the fungus, but the deficiency of this receptor 
could cause the lack of some specific response to the 
injury. Therefore, the combined effect of the fungus 
and the infection route may generate the phenomenon 
that no difference was detected between the survival of 
the C. albicans- and the C. parapsilosis strains- 
challenged GNBP3hades fly groups. Results from 
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gastrointestinal infection of Drosophila larvae also 
registered that absence of GNBP3 receptor did not 
influence systemic activation of Drosomycin and dou-
ble mutant psh; GNBP3 larvae exhibited a similar 
decrease in the level of the antimicrobial peptide as 
psh mutants following infection with live C. albicans 
[18]. This study suggests the altered immune sensing 
processes, including the role of GNBP3 between the 
larvae and adult fly and the Drosophila gut and sys-
temic infection model. The mammalian β-glucan 
receptor, Dectin-1, displays a similar feature. In mice, 
Dectin-1 is indispensable in regulating systemic infec-
tion with C. albicans, but it performs a redundant role 
for the control of gastrointestinal colonization [39]. 
Furthermore, a comparative study established that 
Dectin-1 is essential for both innate and adaptive 
immune responses to C. albicans, C. glabrata, 
C. tropicalis and C. parapsilosis; however, its function 
in specific responses diverge between the different 
Candida species [40]. Overall, our data show decreased 
survival and reduced ability of GNBP3hades fly to clear 
C. parapsilosis cells, but, due to the confusing results 
described earlier, it is challenging to resolve the real 
effect of this receptor in Drosophila host response in 
the control of systemic C. parapsilosis dissemination.
As a measure of the adult Drosophila’s immune recogni-
tion process, we examined whether blood cells circulating in 
hemolymph engulf C. parapsilosis cells after septic infection. 
Representative microscopical pictures demonstrated that 
phagocytosis of C. parapsilosis and C. albicans cells occurred 
in vivo. It is interesting that GNBP3 is required for C. albicans 
cells agglutination, prophenoloxidase activation and forma-
tion of attack complexes combating this pathogen. All the 
same time, phagocytosis of C. albicans cells was not affected 
by this sensor molecule’s presence or absence [32]. 
Meanwhile, these defense functions vary between different 
Candida strains, as C. glabrata cells are not agglutinated and 
they do not entirely trigger the PO cascade in a GNBP3- 
dependent manner, which occurs with C. albicans [16]. Our 
experiments have limitations as additional elements of the 
cellular arm of protection in Drosophila (e.g. agglutination or 
PO formation) were not examined. Our results could point 
to other recognition receptors that might be at play in 
regulating C. parapsilosis infection in Drosophila as the 
Persephone mutant flies were resistant to C. parapsilosis 
and according to a previous research engulfment of 
C. albicans cells was not dependent on the GNBP3 receptor 
[32]. More detailed studies are needed to obtain deeper 
insights and decipher the cellular arm of the Drosophila 
immune defense and elimination mechanisms against 
C. parapsilosis.
Taken together, our results demonstrate the impor-
tance of a well-functioning Drosophila Toll pathway to 
hinder C. parapsilosis infection, and we established the 
utility of the MyD88−/- Drosophila model to analyze 
differences in the virulence properties of 
C. parapsilosis and related strains.
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